NeoCura

About:

NeoCura provides an AI medical platform to improve the precision diagnosis and treatment of tumors.

Top Investors: CDH Investments, IDG Capital, Shunxi Fund, Alwin Capital, PICC Capital Investment Management

Description:

NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.

Total Funding Amount:

750M CNY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2017-01-01

Contact Email:

info(AT)neocura.net

Founders:

Number of Employees:

101-250

Last Funding Date:

2021-12-21

IPO Status:

Private

Industries:

Health Care

Biotechnology

Artificial Intelligence (AI)

Software